MEDIX BIOCHEMICA
LIVE

Serial Number

79358529

Owner

Oy Medix Biochemica Ab

Attorney

ROGER H. BORA

Filing Date

May 19, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MEDIX BIOCHEMICA Trademark

Serial Number: 79358529 • Registration: 7636487

MEDIX BIOCHEMICA is a trademark filed by Oy Medix Biochemica Ab on May 19, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Oy Medix Biochemica Ab (4 trademarks)

Klovinpellontie 1-3
Espoo 02180 , FI

Entity Type: 09

Trademark Details

Filing Date

May 19, 2022

Registration Date

January 7, 2025

Published for Opposition

November 19, 2024

Goods & Services

Medical and scientific research; pharmaceutical research and development; development of antibodies for others; antibody research and development services; development of assays for diagnostic purposes; medical laboratories; conducting clinical trials; scientific research consulting services in the field of medical and health care technology; medical and pharmacological research; providing of information and data relating to medical research and development; product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays; monoclonal antibody research and development services

Medical testing devices utilizing immunological methods, in the form of kits primarily comprised of test strips capable of visual or instrument read out of test results, buffer tubes, medical specimen collection loops and vials, for use in testing of blood, plasma, serum, and other bodily fluids, and also including cotton swabs and pads for medical purposes; medical diagnostic instruments for in vitro diagnostic testing and in vitro analysis utilizing immunological methods for use in the field of immunology, anesthesia, dermatology, neurology, obstetrics, gynecology, reproductive biology, broncology, pulmonology, respiratology, ophthalmology, orthopedic surgery, otology, laryngology, pathology, pediatrics, radiology, radiation, oncology, and surgery; medical apparatus and instruments, namely, diagnostic testing apparatus and instruments for medical use for use in in vitro diagnostic testing procedures, cardiovascular diagnosis and screening, diabetes monitoring and diagnosis, pregnancy monitoring, monitoring and diagnosing metabolic functions, detecting, screening and monitoring infectious diseases, inflammatory diseases, skin disorders, thyroid diseases and cancer; medical apparatus and instruments, namely, diagnostic testing apparatus and instruments for blood analysis, urine analysis, fecal analysis, saliva analysis, analysis of oral fluids, analysis of amniotic fluids, analysis of cervicospinal fluid, analysis of ascites, analysis of pleural fluids, analysis of exudate, analysis of cervical, vaginal and cervico-vaginal secretions; in-vitro diagnostic apparatus, in the form of test kits for medical purposes for professional or home use comprised of collection pads or swabs, collection loops or vials, test strips capable of visual or instrument read out of test results and/or vials of developer solution or reagents; in-vitro diagnostic apparatus, in the form of test kits for medical purposes for professional or home use for analysing oral fluid, urine, feces, amniotic fluid, vaginal secretions, cervical secretions, cervico-vaginal secretions, finger stick or venipuncture whole blood, plasma, serum, exudate, skin, cervicospinal fluid, ascites, pleural fluids, other bodily fluids and specimens; in-vitro diagnostic apparatus, in the form of test kits for medical purposes for professional or home use for use in detecting antibodies, antigen, viruses, bacteria and other pathogens, disease markers and metabolites, fecal occult blood, hormones, vitamins, proteins, nucleic acids, toxins, drugs and their metabolites, drugs of abuse and chemicals

Chemical reagents for medical or veterinary purposes; medical diagnostic reagents; veterinary diagnostic reagents; reagents for medical use; chemical and biological antigens for medical diagnostic use; clinical medical reagents; pharmaceutical preparations for diagnostic purposes; monoclonal antibodies for medical and diagnostic use; pregnancy and fertility test kits for home and medical use; medical diagnostic test strips for home and medical use for use in the fields of immunology, dermatology, neurology, obstetrics, gynecology, reproductive biology, broncology, pulmonology, respiratology, ophthalmology, orthopedic surgery, otology, laryngology, pathology, pediatrics and oncology; diagnostic preparations for medical use; reagent media for medical diagnostic purposes; medical immunological diagnostic reagents; diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; protein arrays for diagnosing cancer; monoclonal antibodies for use in disease testing; leukocyte antibodies for use in disease testing; cytokines and chemokines for use in disease testing; adhesion molecules for use in disease testing; endothelial cells for medical use; progenitor cells for medical use; medical diagnostic reagents and assays for detecting apoptosis; medical diagnostic reagents for cellular transduction; stem cells for medical use

Providing medical information, consultation and advisory services; medical consulting services in the field of diagnostics; medical consulting regarding medical diagnostic apparatus and instruments; medical consulting regarding diagnostic preparations; providing medical information through a website; medical diagnostic testing and reporting services; tissue typing services in the nature of blood testing

Reagents for use in scientific and medical research; diagnostic preparations for medical research; reagent media for medical research; chemical test paper; protein arrays and nucleotide arrays for scientific and medical research; diagnostic preparations for scientific or research use; antibodies for use in scientific and medical research in the nature of mononuclean antibodies; assays for research purposes; buffer solutions for use in analytical chemistry; control reagents for research purposes for use with scientific apparatus and instruments; protein labelling kits comprising reagents for use in scientific and medical research; assay kits consisting of chemical reagents for scientific and medical research; assay kits consisting of biological reagents for scientific and medical research; protein in raw material form for scientific and medical research; proteins in raw material form for scientific and medical research for detecting antibodies; diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; chemicals for use in biotechnological manufacturing processes and product development; nucleotides for scientific and research use; proteins for use in manufacture; reagent medium for medical research

Manufacturing of diagnostic preparations and reagent medium to order for medical use and medical research and non-medical purposes; manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, diagnostics, health care products and medical products; treatment of materials, namely, pharmaceutical, diagnostic and chemical products and their components used in the manufacture of pharmaceuticals, biopharmaceuticals, diagnostic preparations, reagent media, test kits, testing apparatus and instruments; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, diagnostic preparations and reagent medium

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 19, 2026 NREP
IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Jul 12, 2025 IRFI
FINAL DISPOSITION NOTICE SENT TO IB
Jul 2, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 2, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 7, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
EXPARTE APPEAL TERMINATED
Oct 10, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 10, 2024 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 30, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 7, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 7, 2024 OPNR
EX PARTE APPEAL-INSTITUTED
Mar 28, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 28, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Mar 28, 2024 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 15, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 29, 2023 GNFN
FINAL REFUSAL E-MAILED
Sep 29, 2023 GNFR
FINAL REFUSAL WRITTEN
Sep 29, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2023 TROA
NON-FINAL ACTION MAILED
Mar 14, 2023 CNRT
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 13, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 13, 2023 ZZZX
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Mar 13, 2023 PBSR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2023 CNSA
ASSIGNED TO EXAMINER
Mar 9, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 31, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 27, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 23, 2022 REPR